Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Growth hormone injections deliver a synthetic growth hormone to the body to treat hormone deficiencies and other health ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes. CATT1 Phase 3 trial expected to ...

DKA at T1D diagnosis, compared with no DKA, was associated with worse glycemic control outcomes and BMI among pediatric patients.

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

The Affordable Insulin Now Act, as it is known ... Unfortunately, the current drug pricing bill fails to take a holistic approach to addressing a system that drives affordability challenges ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes CATT1 Phase 3 trial expected to resume following submission of protocol amendment shortening the overall durati ...

has announced that the US Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old ...

IT’S hard to imagine a time when the word ‘Ozempic’ wasn’t part of our vocabulary.  For years, celebs have embraced the ...